SCHEMBL16015253

SCHEMBL16015253

CC[C@@H]1CCCN(C(=O)c2ccccc2OC)C1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.63
POLB P06746 2/20 0.60
CYP2C9 P11712 2/20 0.58
CYP2C19 P33261 2/20 0.58
MAPK14 Q16539 1/20 0.58
PDE2A O00408 2/20 0.53
PDE3B Q13370 1/20 0.53
TSHR P16473 3/20 0.53
KDM2B Q8NHM5 2/20 0.52
ALDH1A1 P00352 1/20 0.52
KMT2A Q03164 4/20 0.52
MEN1 O00255 2/20 0.52
CYP3A4 P08684 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
CCR5 P51681 1/20 0.51
LMNA P02545 1/20 0.50
HSD11B1 P28845 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23409072 0.83 TSHR (0.53) POLBCYP2C9CYP2C19TSHRALDH1A1
SCHEMBL2540114 0.79 HTT (0.90) HTTPOLBCYP2C9CYP2C19MAPK14
SCHEMBL12424605 0.79 ALDH1A1 (0.56) POLBALDH1A1LMNAHSD11B1
SCHEMBL24486493 0.79 ALDH1A1 (0.56) POLBALDH1A1LMNAHSD11B1
SCHEMBL21926835 0.78 POLB (0.73) HTTPOLBTSHRALDH1A1KMT2A
SCHEMBL2535573 0.78 HTT (0.88) HTTPOLBCYP2C9CYP2C19MAPK14
SCHEMBL17502718 0.78 HTT (0.62) HTTPOLBCYP2C9CYP2C19MAPK14
SCHEMBL17502656 0.78 HTT (0.62) HTTPOLBCYP2C9CYP2C19MAPK14
SCHEMBL19766699 0.76 HTT (0.90) HTTPOLBCYP2C9CYP2C19MAPK14
SCHEMBL11714770 0.76 HTT (0.90) HTTPOLBCYP2C9CYP2C19MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9345708-B2 Inhibitors of influenza viruses replication VERTEX PHARMACEUTICALS INCORPORATED (US) 2016-05-24 US disclosed
US-8829007-B2 Inhibitors of influenza viruses replication VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-09-09 US disclosed